2,2,2-三氟乙基磺酰氯 | 1648-99-3

• 物质功能分类: 化学试剂 - 有机试剂 - 磺酰卤化物
• 分子结构分类: 有机化合物 - 有机卤素化合物 - 磺酰卤
• 中文名称: 2,2,2-三氟乙基磺酰氯
• 中文别名: 2,2,2-三氟-乙硫酰氯；2,2,2-三氟乙烷磺酰氯；2,2,2-三氟-1-(噻吩-2-基)乙胺
• 英文名称: 2,2,2-Trifluoroethanesulfonyl chloride
• 英文别名: (2,2,2-trifluoroethyl)sulfonyl chloride；2,2,2-trifluoroethane-1-sulfonyl chloride
• CAS: 1648-99-3
• 化学式: C₂H₂ClF₃O₂S
• mdl: MFCD00007458
• 分子量: 182.551
• InChiKey: CXCHEKCRJQRVNG-UHFFFAOYSA-N

物化性质

• 沸点：
  140-141 °C (lit.) 64-67 °C/45 mmHg (lit.)
• 密度：
  1.651 g/mL at 25 °C (lit.)
• 闪点：
  162 °F
• 稳定性/保质期：
  在常温常压下保持稳定，避免氧化物接触。

计算性质

• 辛醇/水分配系数(LogP)：
  1.5
• 重原子数：
  9
• 可旋转键数：
  1
• 环数：
  0.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  42.5
• 氢给体数：
  0
• 氢受体数：
  5

安全信息

• 危险等级：
  8
• 危险品标志：
  C
• 安全说明：
  S26,S36/37/39,S45
• 危险类别码：
  R34
• WGK Germany：
  3
• 海关编码：
  2904909090
• 危险品运输编号：
  UN 3265 8/PG 2
• 包装等级：
  III
• 危险类别：
  8
• 危险性防范说明：
  P280,P305+P351+P338,P310
• 危险性描述：
  H314
• 储存条件：
  在4°C条件下密封保存

SDS

Name:	2 2 2-Trifluoroethanesulfonyl Chloride 99 % Material Safety Data Sheet
Synonym:	Tresyl Chloride
CAS:	1648-99-3

Section 1 - Chemical Product MSDS Name:2 2 2-Trifluoroethanesulfonyl Chloride 99 % Material Safety Data Sheet
Synonym:Tresyl Chloride

---

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS

CAS#	Chemical Name	content	EINECS#
1648-99-3	2,2,2-Trifluoroethanesulfonyl Chloride	99%	216-713-7

Hazard Symbols: C
Risk Phrases: 34

---

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Causes burns.Moisture sensitive.Lachrymator (substance which increases the flow of tears).Corrosive.
Potential Health Effects
Eye:
Causes eye burns. Lachrymator (substance which increases the flow of tears).
Skin:
Causes skin burns.
Ingestion:
May cause severe and permanent damage to the digestive tract. Causes gastrointestinal tract burns.
Inhalation:
May cause irritation of the respiratory tract with burning pain in the nose and throat, coughing, wheezing, shortness of breath and pulmonary edema. Causes chemical burns to the respiratory tract.
Inhalation may be fatal as a result of spasm, inflammation, edema of the larynx and bronchi, chemical pneumonitis and pulmonary edema.
Chronic:
No information found.

---

Section 4 - FIRST AID MEASURES
Eyes: Get medical aid immediately. Do NOT allow victim to rub eyes or keep eyes closed. Extensive irrigation with water is required (at least 30 minutes).
Skin:
Get medical aid immediately. Immediately flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Wash clothing before reuse. Destroy contaminated shoes.
Ingestion:
Do not induce vomiting. If victim is conscious and alert, give 2-4 cupfuls of milk or water. Never give anything by mouth to an unconscious person. Get medical aid immediately.
Inhalation:
Get medical aid immediately. Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Do NOT use mouth-to-mouth resuscitation. If breathing has ceased apply artificial respiration using oxygen and a suitable mechanical device such as a bag and a mask.
Notes to Physician:

---

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion. Will burn if involved in a fire. Use water spray to keep fire-exposed containers cool. Combustible liquid. Vapors may be heavier than air.
They can spread along the ground and collect in low or confined areas. Containers may explode when heated.
Extinguishing Media:
Use water spray to cool fire-exposed containers. Use agent most appropriate to extinguish fire. Do NOT get water inside containers.
Use water spray, dry chemical, carbon dioxide, or appropriate foam.

---

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Absorb spill with inert material (e.g. vermiculite, sand or earth), then place in suitable container. Avoid runoff into storm sewers and ditches which lead to waterways. Clean up spills immediately, observing precautions in the Protective Equipment section. Remove all sources of ignition. Use a spark-proof tool. Provide ventilation. Do not get water inside containers.

---

Section 7 - HANDLING and STORAGE
Handling:
Wash thoroughly after handling. Avoid contact with eyes, skin, and clothing. Do not breathe dust, vapor, mist, or gas. Empty containers retain product residue, (liquid and/or vapor), and can be dangerous.
Keep away from heat, sparks and flame. Avoid ingestion and inhalation. Use with adequate ventilation. Do not allow contact with water. Discard contaminated shoes. Do not pressurize, cut, weld, braze, solder, drill, grind, or expose empty containers to heat, sparks or open flames. Keep from contact with moist air and steam.
Storage:
Keep away from heat, sparks, and flame. Keep away from sources of ignition. Keep container closed when not in use. Keep under a nitrogen blanket. Store in a cool, dry, well-ventilated area away from incompatible substances. Keep refrigerated. (Store below 4C/39F.) Store protected from moisture.

---

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 1648-99-3: Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to minimize contact with skin.
Respirators:
A respiratory protection program that meets OSHA's 29 CFR 1910.134 and ANSI Z88.2 requirements or European Standard EN 149 must be followed whenever workplace conditions warrant respirator use.

---

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Liquid
Color: colorless
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: 64 - 67 deg C @ 45.00mm Hg
Freezing/Melting Point: Not available.
Autoignition Temperature: Not available.
Flash Point: 72 deg C ( 161.60 deg F)
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density: 1.6510g/cm3
Molecular Formula: C2H2ClF3O2S
Molecular Weight: 182.55

---

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stable at room temperature in closed containers under normal storage and handling conditions.
Conditions to Avoid:
Incompatible materials, ignition sources, moisture, excess heat, exposure to moist air or water.
Incompatibilities with Other Materials:
Oxidizing agents.
Hazardous Decomposition Products:
Hydrogen chloride, carbon monoxide, oxides of sulfur, irritating and toxic fumes and gases, carbon dioxide, hydrogen fluoride gas.
Hazardous Polymerization: Has not been reported

---

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 1648-99-3 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
2,2,2-Trifluoroethanesulfonyl Chloride - Not listed by ACGIH, IARC, or NTP.

---

Section 12 - ECOLOGICAL INFORMATION

---

Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

---

Section 14 - TRANSPORT INFORMATION

IATA
Shipping Name: CORROSIVE LIQUID, ACIDIC, ORGANIC, N.O.S.*
Hazard Class: 8
UN Number: 3265
Packing Group: II
IMO
Shipping Name: CORROSIVE LIQUID, ACIDIC, ORGANIC, N.O.S.
Hazard Class: 8
UN Number: 3265
Packing Group: II
RID/ADR
Shipping Name: CORROSIVE LIQUID, ACIDIC, ORGANIC, N.O.S.
Hazard Class: 8
UN Number: 3265
Packing group: II

---

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: C
Risk Phrases:
R 34 Causes burns.
Safety Phrases:
S 23 Do not inhale gas/fumes/vapour/spray.
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 27 Take off immediately all contaminated clothing.
S 28A After contact with skin, wash immediately with
plenty of water.
S 36/37/39 Wear suitable protective clothing, gloves
and eye/face protection.
S 37 Wear suitable gloves.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
WGK (Water Danger/Protection)
CAS# 1648-99-3: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 1648-99-3 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 1648-99-3 is not listed on the TSCA inventory.
It is for research and development use only.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  2,2,2-三氟乙基磺酰氯 在 水 作用下， 反应 1.5h， 以80%的产率得到2,2,2-trifluoroethanesulfonic acid
  参考文献：
  名称：

  2,2,2-三氟乙烷磺酰氯水解中的可逆和不可逆ElcB机理：水溶液中的碳负离子中间体（1）。

  摘要：

  2,2,2-三氟乙烷磺酰氯（1）的水解表明是通过亚砜（CF（3）CH = SO（2））发生的，该亚砜由（a）在pH范围1.8内不可逆的E1cB过程形成-5在较低的pH范围内用水作为形成碳负离子的碱，在较高的pH范围内用作氢氧根阴离子，以及（b）在稀酸中可逆的E1cB反应。

  DOI：

  10.1021/jo971872v
• 作为产物：
  描述：

  di-H-trifluoroethane-2-sulfonyl fluoride 在 三氯化铝 作用下， 生成 2,2,2-三氟乙基磺酰氯
  参考文献：
  名称：

  Fluorine-containing ?-sultones 47. Derivatives of 2,2,2-trifluoroethanesulfonic acid

  摘要：

  DOI：

  10.1007/bf00929234
• 作为试剂：
  描述：

  2'-O-acetyl-7α-paclitaxel 在 4-二甲氨基吡啶 、 2,2,2-三氟乙基磺酰氯 作用下， 以 吡啶 为溶剂， 反应 4.0h， 以52%的产率得到2'-O-acetyl-Δ^6,7-paclitaxel
  参考文献：
  名称：

  Menichincheri, Maria; Botta, Maurizio; Ceccarelli, Walter, Medicinal Chemistry Research, 1995, vol. 5, # 7, p. 534 - 556

  摘要：

  DOI：

文献信息

• [EN] SUBSTITUTED PYRIDINONE-CONTAINING TRICYCLIC COMPOUNDS, AND METHODS USING SAME<br/>[FR] COMPOSÉS TRICYCLIQUES CONTENANT DE LA PYRIDINONE SUBSTITUÉE, ET PROCÉDÉS LES UTILISANT
  申请人：ARBUTUS BIOPHARMA INC

  公开号：WO2018085619A1

  公开（公告）日：2018-05-11

  The present invention includes substituted pyridinone-containing tricyclic compounds, and compositions comprising the same, that can be used to treat or prevent hepatitis B virus (HBV) infection in a patient. In certain embodiments, the compounds and compositions of the invention inhibit and/or reduce HBsAg secretion.

  本发明涵盖了含有取代吡啶酮的三环化合物，以及包含这些化合物的组合物，可用于治疗或预防患者体内的乙型肝炎病毒（HBV）感染。在某些实施方式中，本发明的化合物和组合物抑制和/或减少HBsAg的分泌。
• [EN] ANTIOXIDANT INFLAMMATION MODULATORS: C-17 HOMOLOGATED OLEANOLIC ACID DERIVATIVES<br/>[FR] MODULATEURS D'INFLAMMATION ANTIOXYDANTS : DÉRIVÉS D'ACIDE OLÉANOLIQUE HOMOLOGUÉS C-17
  申请人：REATA PHARMACEUTICALS INC

  公开号：WO2009129548A1

  公开（公告）日：2009-10-22

  This invention provides, but is not limited to, novel oleanolic acid derivatives having the formula (I) wherein the variables are defined herein. Also provided are pharmaceutical compositions, kits and articles of manufacture comprising such compounds, methods and intermediates useful for making the compounds, and methods of using the compounds and compositions.

  这项发明提供了具有以下式(I)的新奥齐酸衍生物，其中变量在此处定义。还提供了包括这些化合物的药物组合物、试剂盒和制造物品，用于制备这些化合物的有用中间体和方法，以及使用这些化合物和组合物的方法。
• Triazole antifungal agents
  申请人：Pfizer Inc.

  公开号：US05023258A1

  公开（公告）日：1991-06-11

  The invention provides triazole antifungal compounds of the formula: ##STR1## wherein R is either (a) a phenyl group optionally substituted with 1 to 3 substituents, each selected independently from halo and CF.sub.3 ; or (b) a 5-chloropyridin-2-yl group; and R.sup.1 is either (a) a phenyl group, para-substituted by a group selected from the following: ##STR2## or (b) a 2-, 3- or 4-pyridinyl group optionally substituted with a group of the formula ##STR3##

  该发明提供了式子为：##STR1##的三唑类抗真菌化合物，其中R是（a）一个苯基，可选地取代为1到3个取代基，每个取代基独立地选自卤素和CF.sub.3；或者（b）一个5-氯吡啶-2-基基团；而R.sup.1是（a）一个苯基，对位取代为以下群之一：##STR2##或者（b）一个2-、3-或4-吡啶基团，可选地取代为式子##STR3##的一个群。
• Direct Catalytic Asymmetric Mannich-Type Reaction of α- and β-Fluorinated Amides
  作者：Lennart Brewitz、Fernando Arteaga Arteaga、Liang Yin、Kaliyamoorthy Alagiri、Naoya Kumagai、Masakatsu Shibasaki

  DOI：10.1021/jacs.5b11064

  日期：2015.12.23

  emergence of direct enolization protocols providing atom-economical and operationally simple methods to use enolates for stereoselective C-C bond-forming reactions, eliminating the inherent drawback of the preformation of enolates using stoichiometric amounts of reagents. In its infancy, direct enolization relied heavily on the intrinsic acidity of the latent enolates, and the reaction scope was limited

  过去二十年见证了直接烯醇化方案的出现，提供了原子经济且操作简单的方法来使用烯醇化物进行立体选择性 CC 键形成反应，消除了使用化学计量量的试剂预先形成烯醇化物的固有缺点。在其初期，直接烯醇化严重依赖潜在烯醇化物的固有酸性，反应范围仅限于易于烯醇化的酮和醛。该领域的最新进展使开发羧酸衍生物直接烯醇化成为可能，从而提供了合成通用手性构件的快速途径。尽管对富含对映体的含氟小分子的需求不断增长，由于竞争性和主导性的脱氟途径，α-和β-氟化羰基化合物在直接烯醇化化学中被忽略。在此，我们对 α- 和 β-氟官能化 7-氮杂吲哚啉酰胺的直接和高度立体选择性曼尼希型反应进行了全面研究，该反应依赖于软路易斯酸/硬布朗斯台德碱协同催化体系来保证有效的烯醇化，同时抑制不需要的脱氟。该协议有助于为药物化学提供一系列富含对映体的 β-氨基酸的氟化类似物。在此，我们对 α- 和 β-氟官能化 7-氮杂吲哚啉酰胺的直接
• [EN] PYRIDINYL DERIVATIVES AS INHIBITORS OF ENZYME NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE<br/>[FR] DÉRIVÉS DE PYRIDINYLE UTILISÉS EN TANT QU'INHIBITEURS DE L'ENZYME NICOTINAMIDE PHOSPHORIBOSYLTRANSFÉRASE
  申请人：TOPOTARGET AS

  公开号：WO2010142735A1

  公开（公告）日：2010-12-16

  The present application discloses a compound of the formula (I) wherein Q is optionally substituted pyridyl; p is 0-6; Y is formulae (i), (ii) and (iii) where X is =O, =S and =N-CN, r is 1-12, R is -Z-A, Z is a single bond, -S(=O)2-, >P=O, >C=O, -C(=O)NH-, and -C(=S)NH-; and A is hydrogen, C1-12-alkyl, C3-12-cycloalkyl, - [CH2CH2O]1-10-(C1-6-alkyl), C1-12-alkenyl, aryl, heterocyclyl, and heteroaryl; B is a single bond, -NRN-, -S(=O)2- and -O-; wherein RN is selected from hydrogen, C1-12-alkyl, C3-12-cycloalkyl, -[CH2CH2O]1-10-(C1-6-alkyl), C1-12-alkenyl, aryl, heterocyclyl, and heteroaryl; s is 0-6; and Cy is aryl, cycloalkyl, heterocyclyl, and heteroaryl. The compounds are usefuld for use as a medicament for the treatment of a disease or a condition caused by an elevated level of nicotinamide phosphoribosyltransferase (NAMPRT).

  本申请公开了一种化合物，其化学式为（I），其中Q是可选择取代的吡啶基；p为0-6；Y是式（i）、（ii）和（iii），其中X为=O、=S和=N-CN，r为1-12，R为-Z-A，Z为单键，-S(=O)2-，>P=O，>C=O，-C(=O)NH-和-C(=S)NH-；A为氢、C1-12-烷基、C3-12-环烷基、-[CH2CH2O]1-10-(C1-6-烷基)、C1-12-烯基、芳基、杂环烷基和杂芳基；B为单键，-NRN-，-S(=O)2-和-O-；其中RN从氢、C1-12-烷基、C3-12-环烷基、-[CH2CH2O]1-10-(C1-6-烷基)、C1-12-烯基、芳基、杂环烷基和杂芳基中选择；s为0-6；Cy为芳基、环烷基、杂环烷基和杂芳基。这些化合物可用作治疗由烟酰胺磷酸核糖转移酶（NAMPRT）水平升高引起的疾病或症状的药物。

表征谱图